Christopher R. Shepard

898 total citations
4 papers, 735 citations indexed

About

Christopher R. Shepard is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Christopher R. Shepard has authored 4 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 1 paper in Cardiology and Cardiovascular Medicine. Recurrent topics in Christopher R. Shepard's work include Wnt/β-catenin signaling in development and cancer (3 papers), Cancer Cells and Metastasis (3 papers) and Adipose Tissue and Metabolism (1 paper). Christopher R. Shepard is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (3 papers), Cancer Cells and Metastasis (3 papers) and Adipose Tissue and Metabolism (1 paper). Christopher R. Shepard collaborates with scholars based in United States. Christopher R. Shepard's co-authors include Alan Wells, Yvonne Chao, Clayton Yates and Qian Wu and has published in prestigious journals such as Molecular Cancer, Frontiers in Endocrinology and Clinical & Experimental Metastasis.

In The Last Decade

Christopher R. Shepard

4 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher R. Shepard United States 4 412 411 190 112 85 4 735
Salvatore A. Del Prete United States 10 307 0.7× 374 0.9× 154 0.8× 99 0.9× 88 1.0× 13 665
Alison G. Barber United States 6 413 1.0× 256 0.6× 170 0.9× 68 0.6× 79 0.9× 8 639
Yanhua Xuan China 18 539 1.3× 381 0.9× 221 1.2× 115 1.0× 77 0.9× 47 884
Eric Sceusi United States 6 424 1.0× 419 1.0× 227 1.2× 49 0.4× 53 0.6× 10 704
Julia Mitschke Germany 6 545 1.3× 464 1.1× 351 1.8× 99 0.9× 93 1.1× 7 890
Yvonne Chao United States 8 528 1.3× 397 1.0× 192 1.0× 154 1.4× 154 1.8× 11 881
Abdo J. Najy United States 14 367 0.9× 222 0.5× 180 0.9× 111 1.0× 47 0.6× 23 618
Marisol González-Huarriz Spain 14 419 1.0× 314 0.8× 237 1.2× 72 0.6× 41 0.5× 25 734
Peter Čamaj Germany 16 507 1.2× 355 0.9× 279 1.5× 78 0.7× 53 0.6× 22 788
Naheed Gul United States 7 401 1.0× 373 0.9× 231 1.2× 89 0.8× 55 0.6× 11 790

Countries citing papers authored by Christopher R. Shepard

Since Specialization
Citations

This map shows the geographic impact of Christopher R. Shepard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher R. Shepard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher R. Shepard more than expected).

Fields of papers citing papers by Christopher R. Shepard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher R. Shepard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher R. Shepard. The network helps show where Christopher R. Shepard may publish in the future.

Co-authorship network of co-authors of Christopher R. Shepard

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher R. Shepard. A scholar is included among the top collaborators of Christopher R. Shepard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher R. Shepard. Christopher R. Shepard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Shepard, Christopher R.. (2021). TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism. Frontiers in Endocrinology. 11. 613639–613639. 41 indexed citations
2.
Chao, Yvonne, Qian Wu, Christopher R. Shepard, & Alan Wells. (2011). Hepatocyte induced re-expression of E-cadherin in breast and prostate cancer cells increases chemoresistance. Clinical & Experimental Metastasis. 29(1). 39–50. 72 indexed citations
3.
Chao, Yvonne, Christopher R. Shepard, & Alan Wells. (2010). Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Molecular Cancer. 9(1). 179–179. 333 indexed citations
4.
Wells, Alan, Clayton Yates, & Christopher R. Shepard. (2008). E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clinical & Experimental Metastasis. 25(6). 621–628. 289 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026